Trials and tribulations with VH replacement

Frontiers in Immunology

Volumn 5, Issue JAN, 2014, Pages

  Meng, Wenzhao ^a   Jayaraman, Sahana ^a   Zhang, Bochao ^b   Schwartz, Gregory W ^b   Daber, Robert D ^a,c   Hershberg, Uri ^b,d   Garfall, Alfred L ^c   Carlson, Christopher S ^e   Luning Prak, Eline T ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b DREXEL UNIVERSITY   (United States)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

^d DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

^e Fred Hutchinson Cancer Research Center   (United States)

Author keywords

And JH gene segments; DH; Receptor editing; V(D)J recombination; VH; VH replacement

Indexed keywords

B LYMPHOCYTE RECEPTOR;

ACUTE LYMPHOBLASTIC LEUKEMIA; ARTICLE; B LYMPHOCYTE; BONE MARROW; CHRONIC GRAFT VERSUS HOST DISEASE; COMPLEMENTARITY DETERMINING REGION; DNA FOOTPRINTING; DNA SEQUENCE; GENE; GENE REARRANGEMENT; HIGH THROUGHPUT SEQUENCING; HUMAN; IMMUNOGLOBULIN VARIABLE REGION; NONHUMAN; POLYMERASE CHAIN REACTION; SOMATIC HYPERMUTATION; SYSTEMIC LUPUS ERYTHEMATOSUS; VDJ RECOMBINATION; VH GENE;

EID: 84895521131     PISSN: None     EISSN: 16643224     Source Type: Journal    
DOI: 10.3389/fimmu.2014.00010     Document Type: Article

References (54)

1. Jung D, Giallourakis C, Mostoslavsky R, Alt FW. Mechanism and control of V(D)J recombination at the immunoglobulin heavy chain locus. Annu Rev Immunol (2006) 24:541-70. doi:10.1146/annurev.immunol.23.021704.115830.
2. Gellert M. V(D)J recombination: RAG proteins, repair factors, and regulation. Annu Rev Biochem (2002) 71:101-32. doi:10.1146/annurev.biochem.71.090501.150203.
3. Vinocur JM, Fesnak AD, Liu Y, Charan D, Luning Prak ET. Violations of the 12/23 rule at the mouse immunoglobulin kappa locus, including V kappa-V kappa rearrangement. Mol Immunol (2009) 46:2183-9. doi:10.1016/j.molimm.2009.04.021.
4. Bassing CH, Alt FW, Hughes MM, D'Auteuil M, Wehrly TD, Woodman BB, et al. Recombination signal sequences restrict chromosomal V(D)J recombination beyond the 12/23 rule. Nature (2000) 405:583-6. doi:10.1038/35014635.
5. Briney BS, Willis JR, Hicar MD, Thomas JW II, Crowe JE Jr. Frequency and genetic characterization of V(DD)J recombinants in the human peripheral blood antibody repertoire. Immunology (2012) 137:56-64. doi:10.1111/j.1365-2567.2012.03605.x.
6. Luning Prak ET, Monestier M, Eisenberg RA. B cell receptor editing in tolerance and autoimmunity. Ann N Y Acad Sci (2011) 1217:96-121. doi:10.1111/j.1749-6632.2010.05877.x.
7. Muramatsu M, Kinoshita K, Fagarasan S, Yamada S, Shinkai Y, Honjo T. Class switch recombination and hypermutation require activation-induced cytidine deaminase (AID), a potential RNA editing enzyme. Cell (2000) 102:553-63. doi:10.1016/S0092-8674(00)00078-7.
8. Reynaud CA, Garcia C, Hein WR, Weill JC. Hypermutation generating the sheep immunoglobulin repertoire is an antigen-independent process. Cell (1995) 80:115-25. doi:10.1016/0092-8674(95)90456-5.
9. Darlow JM, Stott DI. Gene conversion in human rearranged immunoglobulin genes. Immunogenetics (2006) 58:511-22. doi:10.1007/s00251-006-0113-6.
10. Duvvuri B, Wu GE. Gene conversion-like events in the diversification of human rearranged IGHV3-23*01 gene sequences. Front Immunol (2012) 3:158. doi:10.3389/fimmu.2012.00158.
11. Darlow JM, Stott DI. V(H) replacement in rearranged immunoglobulin genes. Immunology (2005) 114:155-65. doi:10.1111/j.1365-2567.2004.02084.x.
12. Kleinfield RW, Weigert MG. Analysis of VH gene replacement events in a B cell lymphoma. J Immunol (1989) 142:4475-82.
13. Chen C, Nagy Z, Luning Park ET, Weigert M. Immunoglobulin heavy chain gene replacement: a mechanism of receptor editing. Immunity (1995) 3:747-55. doi:10.1016/1074-7613(95)90064-0.
14. Golub R, Martin D, Bertrand FE, Cascalho M, Wabl M, Wu GE. VH gene replacement in thymocytes. J Immunol (2001) 166:855-60.
15. Taki S, Schwenk F, Rajewsky K. Rearrangement of upstream DH and VH genes to a rearranged immunoglobulin variable region gene inserted into the DQ52-JH region of the immunoglobulin heavy chain locus. Eur J Immunol (1995) 25:1888-96.
16. Wilson PC, Wilson K, Liu YJ, Banchereau J, Pascual V, Capra JD. Receptor revision of immunoglobulin heavy chain variable region genes in normal human B lymphocytes. J Exp Med (2000) 191:1881-94. doi:10.1084/jem.191.11.1881.
17. Itoh K, Meffre E, Albesiano E, Farber A, Dines D, Stein P, et al. Immunoglobulin heavy chain variable region gene replacement As a mechanism for receptor revision in rheumatoid arthritis synovial tissue B lymphocytes. J Exp Med (2000) 192:1151-64. doi:10.1084/jem.192.8.1151.
18. Lenze D, Greiner A, Knörr C, Anagnostopoulos I, Stein H, Hummel M. Receptor revision of immunoglobulin heavy chain genes in human MALT lymphomas. Mol Pathol (2003) 56:249-55. doi:10.1136/mp.56.5.249.
19. Ouled-Haddou H, Ghamlouch H, Regnier A, Trudel S, Herent D, Lefranc M, et al. Characterization of a new V gene replacement in the absence of activation-induced cytidine deaminase and its contribution to human BCR diversity. Immunology (2014) 141:268-75. doi:10.1111/imm.12192.
20. Zhang Z, Wang YH, Zemlin M, Findley HW, Bridges SL, Burrows PD, et al. Molecular mechanism of serial VH gene replacement. Ann N Y Acad Sci (2003) 987:270-3. doi:10.1111/j.1749-6632.2003.tb06060.x.
21. Kowal C, Weinstein A, Diamond B. Molecular mimicry between bacterial and self antigen in a patient with systemic lupus erythematosus. Eur J Immunol (1999) 29:1901-11. doi:10.1002/(SICI)1521-4141(199906)29:06<::AID-IMMU1901>3.0.CO;2-L.
22. Reth M, Gehrmann P, Petrac E, Wiese P. A novel VH to VHDJH joining mechanism in heavy-chain-negative (null) pre-B cells results in heavy-chain production. Nature (1986) 322:840-2. doi:10.1038/322840a0.
23. Cascalho M, Wong J, Wabl M. VH gene replacement in hyperselected B cells of the quasimonoclonal mouse. J Immunol (1997) 159:5795-801.
24. Lutz J, Muller W, Jack HM. VH replacement rescues progenitor B cells with two nonproductive VDJ alleles. J Immunol (2006) 177:7007-14.
25. Rahman NS, Godderz LJ, Stray SJ, Capra JD, Rodgers KK. DNA cleavage of a cryptic recombination signal sequence by RAG1 and RAG2. Implications for partial V(H) gene replacement. J Biol Chem (2006) 281:12370-80. doi:10.1074/jbc.M507906200.
26. Koralov SB, Novobrantseva TI, Konigsmann J, Ehlich A, Rajewsky K. Antibody repertoires generated by VH replacement and direct VH to JH joining. Immunity (2006) 25:43-53. doi:10.1016/j.immuni.2006.04.016.
27. Liu Y, Li L, Kumar KR, Xie C, Lightfoot S, Zhou XJ, et al. Lupus susceptibility genes may breach tolerance to DNA by impairing receptor editing of nuclear antigen-reactive B cells. J Immunol (2007) 179:1340-52.
28. Park YH, Osmond DG. Dynamics of early B lymphocyte precursor cells in mouse bone marrow: proliferation of cells containing terminal deoxynucleotidyl transferase. Eur J Immunol (1989) 19:2139-44. doi:10.1002/eji.1830191125.
29. Davila M, Liu F, Cowell LG, Lieberman AE, Heikamp E, Patel A, et al. Multiple, conserved cryptic recombination signals in VH gene segments: detection of cleavage products only in pro B cells. J Exp Med (2007) 204:3195-208. doi:10.1084/jem.20071224.
30. Vettermann C, Herrmann K, Jack HM. Powered by pairing: the surrogate light chain amplifies immunoglobulin heavy chain signaling and pre-selects the antibody repertoire. Semin Immunol (2006) 18:44-55. doi:10.1016/j.smim.2006.01.001.
31. Keenan RA, De Riva A, Corleis B, Hepburn L, Licence S, Winkler TH, et al. Censoring of autoreactive B cell development by the pre-B cell receptor. Science (2008) 321:696-9. doi:10.1126/science.1157533.
32. Ota M, Duong BH, Torkamani A, Doyle CM, Gavin AL, Ota T, et al. Regulation of the B cell receptor repertoire and self-reactivity by BAFF. J Immunol (2010) 185:4128-36. doi:10.4049/jimmunol.1002176.
33. Hondowicz BD, Alexander ST, Quinn WJ III, Pagán AJ, Metzgar MH, Cancro MP, et al. The role of BLyS/BLyS receptors in anti-chromatin B cell regulation. Int Immunol (2007) 19:465-75. doi:10.1093/intimm/dxm011.
34. Liu J, Lange MD, Hong SY, Xie W, Xu K, Huang L, et al. Regulation of VH replacement by B cell receptor-mediated signaling in human immature B cells. J Immunol (2013) 190:5559-66. doi:10.4049/jimmunol.1102503.
35. Sekiguchi DR, Eisenberg RA, Weigert M. Secondary heavy chain rearrangement: a mechanism for generating anti-double-stranded DNA B cells. J Exp Med (2003) 197:27-39. doi:10.1084/jem.20020737.
36. Eisenberg R. The chronic graft-versus-host model of systemic autoimmunity. Curr Dir Autoimmun (2003) 6:228-44. doi:10.1159/000066864.
37. Brard F, Shannon M, Luning Prak ET, Litwin S, Weigert M. Somatic mutation and light chain rearrangement generate autoimmunity in anti-single-stranded DNA transgenic MRL/lpr mice. J Exp Med (1999) 190:691-704. doi:10.1084/jem.190.5.691.
38. Khan SN, Witsch EJ, Goodman NG, Panigrahi AK, Chen C, Jiang Y, et al. Editing and escape from editing in anti-DNA B cells. Proc Natl Acad Sci U S A (2008) 105:3861-6. doi:10.1073/pnas.0800025105.
39. Sekiguchi DR, Yunk L, Gary D, Charan D, Srivastava B, Allman D, et al. Development and selection of edited B cells in B6.56R mice. J Immunol (2006) 176:6879-87.
40. Yunk L, Meng W, Cohen PL, Eisenberg RA, Luning Prak ET. Antibodies in a heavy chain knock-in mouse exhibit characteristics of early heavy chain rearrangement. J Immunol (2009) 183:452-61. doi:10.4049/jimmunol.0804060.
41. Coleclough C, Perry RP, Karjalainen K, Weigert M. Aberrant rearrangements contribute significantly to the allelic exclusion of immunoglobulin gene expression. Nature (1981) 290:372-8. doi:10.1038/290372a0.
42. Wardemann H, Yurasov S, Schaefer A, Young JW, Meffre E, Nussenzweig MC. Predominant autoantibody production by early human B cell precursors. Science (2003) 301:1374-7. doi:10.1126/science.1086907.
43. Klonowski KD, Primiano LL, Monestier M. Atypical VH-D-JH rearrangements in newborn autoimmune MRL mice. J Immunol (1999) 162:1566-72.
44. Klonowski KD, Monestier M. Heavy chain revision in MRL mice: a potential mechanism for the development of autoreactive B cell precursors. J Immunol (2000) 165:4487-93.
45. Chen C, Bruderer U, Rittenberg MB. The developmental patterns of B cell precursors distinguishing between environmental and nonenvironmental forms of phosphocholine. Cell Immunol (1992) 143:378-88. doi:10.1016/0008-8749(92)90034-M.
46. Binder CJ, Hörkkö S, Dewan A, Chang MK, Kieu EP, Goodyear CS, et al. Pneumococcal vaccination decreases atherosclerotic lesion formation: molecular mimicry between Streptococcus pneumoniae and oxidized LDL. Nat Med (2003) 9:736-43. doi:10.1038/nm876.
47. Watson LC, Moffatt-Blue CS, McDonald RZ, Kompfner E, Ait-Azzouzene D, Nemazee D, et al. Paucity of V-D-D-J rearrangements and VH replacement events in lupus prone and non-autoimmune TdT-/- and TdT+/+ mice. J Immunol (2006) 177:1120-8.
48. Eisenberg RA. Secondary receptor editing in the generation of autoimmunity. Autoimmun Rev (2012) 11:787-9. doi:10.1016/j.autrev.2012.02.004.
49. Choi Y, Greenberg SJ, Du TL, Ward PM, Overturf PM, Brecher ML, et al. Clonal evolution in B-lineage acute lymphoblastic leukemia by contemporaneous VH-VH gene replacements and VH-DJH gene rearrangements. Blood (1996) 87:2506-12.
50. Gawad C, Pepin F, Carlton VE, Klinger M, Logan AC, Miklos DB, et al. Massive evolution of the immunoglobulin heavy chain locus in children with B precursor acute lymphoblastic leukemia. Blood (2012) 120:4407-17. doi:10.1182/blood-2012-05-429811.
51. van derVelden VH, Hochhaus A, Cazzaniga G, Szczepanski T, Gabert J, van Dongen JJ. Detection of minimal residual disease in hematologic malignancies by real-time quantitative PCR: principles, approaches, and laboratory aspects. Leukemia (2003) 17:1013-34. doi:10.1038/sj.leu.2402922.
52. Faham M, Zheng J, Moorhead M, Carlton VE, Stow P, Coustan-Smith E, et al. Deep-sequencing approach for minimal residual disease detection in acute lymphoblastic leukemia. Blood (2012) 120:5173-80. doi:10.1182/blood-2012-07-444042.
53. Zhang Z, Zemlin M, Wang YH, Munfus D, Huye LE, Findley HW, et al. Contribution of Vh gene replacement to the primary B cell repertoire. Immunity (2003) 19:21-31. doi:10.1016/S1074-7613(03)00170-5.
54. Lefranc MP, Giudicelli V, Ginestoux C, Jabado-Michaloud J, Folch G, Bellahcene F, et al. IMGT, the international ImMunoGeneTics information system. Nucleic Acids Res (2009) 37:D1006-12. doi:10.1093/nar/gkn838.